Seegene

Seegene Book Value per Share

The Book Value per Share of Seegene (096530.KQ) as of Oct 29, 2026 is 22,000.38 KRW. In the previous year, Book Value per Share was 21,202.63 KRW — a change of 3.76% (higher).

Book Value per Share

22,000.38KRW

YoY

3.76%

Last updated:

Book Value per Share of Seegene is 2025 22,000.38 KRW. Book Value per Share of Seegene was 2024 21,202.63 KRW. It decreases by 3.76% higher compared to the previous year.

The Seegene Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
2,773.80 KRW
Jan 1, 2019
3,305.07 KRW
Jan 1, 2020
13,981.24 KRW
Jan 1, 2021
23,429.42 KRW
Jan 1, 2022
24,867.27 KRW
Jan 1, 2023
22,265.86 KRW
Jan 1, 2024
21,202.63 KRW
Jan 1, 2025
22,000.38 KRW
The Seegene Book Value per Share history
YEARBook Value per ShareYoY
22,000.38KRW+3.76%
21,202.63KRW-4.78%
22,265.86KRW-10.46%
24,867.27KRW+6.14%
23,429.42KRW+67.58%
13,981.24KRW+323.02%
3,305.07KRW+19.15%
2,773.80KRW+2.39%
2,709.13KRW-11.93%
3,075.94KRW+5.09%
2,926.83KRW+42.58%
2,052.83KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Seegene Stock analysis

What does Seegene do? Seegene, Inc. generates revenue through the manufacturing and distribution of molecular diagnostics and reagents. The company offers infectious pathogens inspection products, including those for allergic respiratory pathogens, sexually transmitted diseases, and human papilloma virus (HPV), alongside drug resistance, single nucleotide polymorphisms (SNP), and somatic mutation cancer inspection products. It also provides automatic real-time detection instruments under the brand names Seeplex, Anyplex, and Magicplex. The firm serves both domestic and overseas markets with these products. The primary customers for Seegene's products are healthcare providers and laboratories requiring diagnostic solutions. The company's product portfolio targets specific medical needs such as infectious disease testing and cancer diagnostics. Its brands Seeplex, Anyplex, and Magicplex are used across various diagnostic applications, including respiratory and sexually transmitted disease testing. The firm's focus on molecular diagnostics positions it within the healthcare sector for specialized testing services. Seegene's revenue streams are derived from the sale of its branded diagnostic products and instruments. The company's domestic and overseas market distribution strategy supports its business model, with Seeplex, Anyplex, and Magicplex serving as key product lines. The firm's offerings cater to the growing demand for accurate and efficient molecular diagnostic solutions in healthcare settings. Seegene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Seegene stock

Book Value per Share of Seegene is 22,000.38 KRW in 2025.

Book Value per Share of Seegene changed from 21,202.63 KRW to 22,000.38 KRW, representing a 3.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Seegene since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Seegene

All Key Metrics — Seegene